IP Library › Assignment 072605/0741
Patent Assignment
Reel/Frame 072605/0741

Change of Name

Recorded: 2025-10-20 Pages: 15
Assignor
CLEARMIND MEDICINE INC.
Executed: 2025-07-28
Assignee
CLEARMIND LABS CORP.
101 – 1220 W 6 AVE, VANCOUVER, V6H1A5, CANADA
Covered Properties (21)
Alcoholic Beverage Substitutes
Application: 15/534,121 →
Publication: US 2017/0360067
Alcoholic Beverage Substitutes
Application: 17/985,979 →
Publication: US 2023/0092839
Binge Behavior Regulators
Application: 15/534,137 →
Publication: US 2018/0085326
Binge Behavior Regulators
Application: 16/167,576 →
Publication: US 2019/0054042
Binge Behavior Regulators
Application: 16/563,974 →
Publication: US 2020/0000747
Binge Behavior Regulators
Application: 17/371,511 →
Publication: US 2021/0330607
Binge Behavior Regulators
Application: 17/371,564 →
Publication: US 2021/0330608
Binge Behavior Regulators
Application: 17/371,626 →
Publication: US 2021/0330609
Binge Behavior Regulators
Application: 19/228,436 →
Publication: US 2025/0288541
2-Fluorodeschloroketamine for Treatment of Depression, Including Treatment-Resistant Depression
Application: 18/701,885 →
Publication: US 2025/0032429
Compositions Comprising Meai and N-Acylethanolamines and Uses Thereof
Application: 18/844,341 →
Publication: US 2025/0302773
Use of 5-Methoxy-2-Aminoindan ("Meai") in Methods for Treating Cocaine Addiction
Application: 18/869,965 →
Use of 5-Methoxy-2-Aminoindan ("Meai") in Methods for Treating Metabolic Syndrome
Application: 19/113,383 →
5-Mapb or 6-Apb for Use in Drug-Assisted Psychotherapy
Application: 18/699,185 →
Publication: US 2024/0423950
Compositions Comprising Lysergic Acid Diethylamide, Optionally in Combination with N-Acylethanolamines and Uses Thereof
Application: 19/154,426 →
Compositions Comprising Psilocybin, Optionally in Combination with N-Acylethanolamines and Uses Thereof
Application: 19/154,428 →
Compositions Comprising N,N-Dimethyltryptamine, Optionally in Combination with N-Acylethanolamines and Uses Thereof
Application: 19/154,431 →
Compositions Comprising 3,4-Methylenedioxymethamphetamine, Optionally in Combination with N-Acylethanolamines, and Uses Thereof
Application: 19/156,483 →
Compositions Comprising Ketamine, Optionally in Combination with N-Acylethanolamines, and Uses Thereof
Application: 19/156,498 →
Compositions Comprising Ibogaine, Optionally in Combination with N-Acylethanolamines, and Uses Thereof
Application: 19/156,530 →
Compositions Comprising 5-Methoxy-2-Aminoindan for Treatment of Depression
Application: 19/469,009 →
Related Assignments (22)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Jan 27, 2022
From: CYNTAR VENTURES, INC.
To: CLEARMIND MEDICINE INC.
Reel/Frame 058797/0479 →
Assignment of Assignor's Interest Jan 27, 2022
From: EZEKIAL GOLAN; DIET ALCOHOL CORPORATION OF THE AMERICAS
To: CYNTAR VENTURES, INC.
Reel/Frame 058796/0583 →
Assignment of Assignor's Interest Jan 28, 2022
From: EZEKIAL GOLAN; DIET ALCOHOL CORPORATION OF THE AMERICAS
To: CYNTAR VENTURES, INC.
Reel/Frame 058802/0720 →
Change of Name Jan 28, 2022
From: CYNTAR VENTURES, INC.
To: CLEARMIND MEDICINE INC.
Reel/Frame 058805/0021 →
Assignment of Assignor's Interest Apr 18, 2024
From: GOLAN, EZEKIEL
To: CLEARMIND MEDICINE INC.
Reel/Frame 067156/0227 →
Assignment of Assignor's Interest Apr 18, 2024
From: GOLAN, EZEKIEL
To: CLEARMIND MEDICINE INC.
Reel/Frame 067156/0405 →
Assignment of Assignor's Interest Sep 26, 2024
From: ZULOFF-SHANI, ADI
To: CLEARMIND MEDICINE INC.
Reel/Frame 068708/0421 →
Assignment of Assignor's Interest Feb 26, 2025
From: YADID, GAL MOSHE
To: BAR-ILAN UNIVERSITY
Reel/Frame 070336/0503 →
Assignment of Assignor's Interest Feb 26, 2025
From: ZULOFF-SHANI, ADI
To: CLEARMIND MEDICINE INC.
Reel/Frame 070336/0375 →
Assignment of Assignor's Interest Oct 15, 2025
From: GOLAN, EZEKIEL; DIET ALCOHOL CORPORATION OF THE AMERICAS
To: CYNTAR VENTURES INC.
Reel/Frame 072582/0538 →
Change of Name Oct 15, 2025
From: CYNTAR VENTURES INC.
To: CLEARMIND MEDICINE INC.
Reel/Frame 073106/0849 →
Assignment of Assignor's Interest Oct 15, 2025
From: TAM, JOSEPH; BARAGHITHY, SAJA
To: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
Reel/Frame 072582/0802 →
Assignment of Assignor's Interest Oct 15, 2025
From: ZULOFF-SHANI, ADI
To: CLEARMIND MEDICINE INC.
Reel/Frame 072582/0852 →
Assignment of Assignor's Interest Oct 20, 2025
From: GOLAN, EZEKIEL; DIET ALCOHOL CORPORATION OF THE AMERICAS
To: CYNTAR VENTURES INC.
Reel/Frame 072605/0676 →
Change of Name Oct 20, 2025
From: CYNTAR VENTURES INC.
To: CLEARMIND MEDICINE INC.
Reel/Frame 073165/0346 →
Assignment of Assignor's Interest Oct 31, 2025
From: ZULOFF-SHANI, ADI
To: CLEARMIND MEDICINE INC.
Reel/Frame 072742/0651 →
Assignment of Assignor's Interest Oct 31, 2025
From: ZULOFF-SHANI, ADI
To: CLEARMIND MEDICINE INC.
Reel/Frame 072742/0645 →
Assignment of Assignor's Interest Oct 31, 2025
From: ZULOFF-SHANI, ADI
To: CLEARMIND MEDICINE INC.
Reel/Frame 072742/0648 →
Assignment of Assignor's Interest Oct 31, 2025
From: ZULOFF-SHANI, ADI
To: CLEARMIND MEDICINE INC.
Reel/Frame 072742/0673 →
Assignment of Assignor's Interest Oct 31, 2025
From: ZULOFF-SHANI, ADI
To: CLEARMIND MEDICINE INC.
Reel/Frame 072742/0654 →
Assignment of Assignor's Interest Oct 31, 2025
From: ZULOFF-SHANI, ADI
To: CLEARMIND MEDICINE INC.
Reel/Frame 072742/0642 →
Assignment of Assignor's Interest Oct 31, 2025
From: ZULOFF-SHANI, ADI
To: CLEARMIND MEDICINE INC.
Reel/Frame 072742/0657 →